Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals Inc.

BCRX

Market Cap$2.25B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biocryst Pharmaceuticals Inc.Biocryst Pharmaceuticals Inc.-42--5.5-
$7.62

Current Fair Value

31% downside

Overvalued by 31% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.25 Billion
Enterprise Value$1.93 Billion
Dividend Yield$0 (0%)
Earnings per Share$-0.43
Beta1.08
Outstanding Shares208,882,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-42
PEG41.96
Price to Sales5.52
Price to Book Ratio5.52
Enterprise Value to Revenue3.84
Enterprise Value to EBIT-247.13
Enterprise Value to Net Income-37
Total Debt to Enterprise0
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Biocryst Pharmaceuticals Inc.

CEO: Jon Stonehouse